Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE210736 |
Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth [scRNAseq+Multiome]
|
|
39 | James Nicholson | Apr 03, 2024 | |||
GSE215318 |
Doxorubicin Changes the Spatial Organization of the Genome around Active Promoters
|
|
21 | Maria Valieva | Mar 31, 2023 | |||
GSE215325 |
Doxorubicin Changes the Spatial Organization of the Genome around Active Promoters
|
|
30 | Maria Valieva | Mar 31, 2023 | |||
GSE244840 |
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions [ChIP-seq]
|
|
5 | Wilbert Zwart | Mar 27, 2024 | |||
GSE115357 |
FBXO11-Mediated Proteolysis of BAHD1 Relieves PRC2-dependent Transcriptional Repression in Erythropoiesis
|
|
50 | Mitch Weiss | Dec 31, 2020 | |||
GSE71780 |
Functional interdependency of BRD4 and DOT1L in MLL leukaemia
|
|
33 | Mark Dawson | Jun 12, 2016 | |||
GSE185066 |
Local euchromatin enrichment in lamina-associated domains anticipates their re-positioning in the adipogenic lineage
|
|
82 | Philippe Collas | Mar 21, 2022 | |||
GSE205348 |
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance
|
|
11 | Irfan Asangani | Jun 08, 2023 | |||
GSE76224 |
Single-cell epigenomic variability reveals functional cancer heterogeneity
|
|
12 | Howard Chang | Dec 12, 2016 | |||
GSE98380 |
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
|
|
30 | William Stanford | Jul 31, 2018 | |||
GSE98378 |
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy [ChIP-Seq]
|
|
24 | William Stanford | Jul 31, 2018 | |||
GSE243020 |
The loss of an orphan nuclear receptor NR2E3 augments Wnt/β-Catenin signaling via epigenetic dysregulation that promotes the Sp1-β catenin-p300 interactions in hepatocellular carcinoma.
|
|
|
8 | Kyounghyun Kim | Aug 26, 2024 | ||
GSE73783 |
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [ChIP-seq]
|
|
3 | Joanna Achinger-Kawecka | Apr 04, 2016 | |||
GSE118946 |
ZBTB12-HERVH-LncRNA axis is a molecular barrier for dedifferentiation of human stem cells
|
|
23 | Guojing Liu | Jun 30, 2021 | |||
GSE34791 |
"Calling Cards" for DNA-binding proteins in mammalian cells
|
|
7 | David Mayhew | Dec 31, 2011 | |||
GSE55904 |
"Drug-seq": An Approach to Identify the Genomic Targets of Chemicals Identified by Functional Phenotypic Screens
|
|
6 | MICHAEL G ROSENFELD | Jul 01, 2014 | |||
GSE55901 |
"Drug-seq": An Approach to Identify the Genomic Targets of Chemicals Identified by Functional Phenotypic Screens [Drug-seq]
|
|
2 | MICHAEL G ROSENFELD | Jul 01, 2014 | |||
GSE273915 |
"The Wild West of Spike-in Normalization": Benchmarking the ChIP-seq spike-in normalization method
|
|
44 | Alon Goren | Aug 05, 2024 | |||
GSE193013 |
(ChIP-seq) USP7 regulates the ncPRC1 Polycomb axis to stimulate genomic H2AK119ub1 deposition uncoupled from H3K27me3
|
|
8 | Yaser Atlasi | Nov 08, 2022 | |||
GSE193014 |
(ChIP-seq) USP7 regulates the ncPRC1 Polycomb axis to stimulate genomic H2AK119ub1 deposition uncoupled from H3K27me3
|
|
8 | Yaser Atlasi | Nov 08, 2022 |